Search
for
Sort by
Research 601–630 of 1000+
- Novel therapies for alopecia areata: The era of rational drug development
- Miniaturization of sebaceous glands: A novel histopathological finding in pemphigus vulgaris and pemphigus foliaceus of the scalp
- Recent Developments in the Treatment of Obesity with Particular Reference to Semistarvation Ketogenic Regimens
- Symptom management in inflammatory bowel disease
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Tinea Capitis: Trends in Spain
- Minimal Incision Face-Lifting
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Psoriatic Alopecia
- Hair loss and its management in children
- Advances in Hair Diseases
- Induction of synapse associated protein 102 expression in cyclosporin A-stimulated hair growth
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Ottawa, Ontario, Canada, February 13–16, 2013
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Follicular Unit Hair Transplantation
- A Case Report of Male Systemic Lupus Erythematous with Antinuclear Antibodies-Negative: A Challenging Diagnosis
- Frontal Fibrosing Alopecia Mimicking Alopecia Syphilitica
- Cutaneous Reactions to Drugs
- Steroid Hormones
- Oxidative Stress in Alopecia Areata and its Association with Disease Severity, Treatment and Autoimmunity
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Debatable Topics in PCOS Patients
- Dermatology and Pregnancy
- Atlas of Geriatric Dermatology
- LUPUS ERYTHEMATOSUS AND THE SKIN
- MALE PATTERN ALOPECIA
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets